Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib
Purpose The association between initial molecular response and longer-term outcomes with nilotinib was examined. Patients and Methods Patients with imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase from the phase II nilotinib registration study with available postbaseline...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2012
|
| In: |
Journal of clinical oncology
Year: 2012, Jahrgang: 30, Heft: 35, Pages: 4323-4329 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2011.40.5217 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1200/JCO.2011.40.5217 Verlag, kostenfrei, Volltext: http://ascopubs.org/doi/10.1200/JCO.2011.40.5217 
|
| Verfasserangaben: | Susan Branford, Dong-Wook Kim, Simona Soverini, Ariful Haque, Yaping Shou, Richard C. Woodman, Hagop M. Kantarjian, Giovanni Martinelli, Jerald P. Radich, Giuseppe Saglio, Andreas Hochhaus, Timothy P. Hughes, and Martin C. Müller |
Search Result 1